Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

Hsueh Y.-M.Lin Y.-C.Chen W.-J.CHAO-YUAN HUANGShiue H.-S.YEONG-SHIAU PUChen C.-H.Su C.-T.2021-02-022021-02-0220180041-008Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85051638573&doi=10.1016%2fj.taap.2018.07.022&partnerID=40&md5=b11ac762e94c0257406b4177b98351e1https://scholars.lib.ntu.edu.tw/handle/123456789/544307[SDGs]SDG3Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))corrigendum10.1016/j.taap.2018.07.022300486682-s2.0-85051638573